Literature DB >> 528700

Bowen's disease and 5-fluorouracil.

H M Sturm.   

Abstract

Sixty-six confirmed cases of Bowen's disease (intraepidermal squamous cell carcinoma) were seen from 1965 through 1976: twenty-four cases were treated surgically-four by excision (two recurrences) and twenty by desiccation and curettage (four recurrences); one was treated with x-ray radiation; and forty-one were treated with topical 5-fluorouracil (5-FU) (three recurrences). Of the six surgical recurrences (25% recurrence), one was retreated by desiccation and curettage and five with 5-FU. Of the three recurrences after 5-FU (8% recurrence), all three were successfully retreated with 5-FU. In view of the generally high recurrence rate after all treatment modalities in Bowen's disease, related to both the ill-defined lateral margins and the frequent follicular involvement with the Bowen's process, prolonged treatment time is required for success with 5-FU. Treatment times employed were 4 to 12 weeks, with a median of 9 weeks. 5-FU concentration ranged from 1% to 3 % in propylene glycol. A 1% concentration of 5-FU was generally adequate on the face, except for occasional recalcitrant areas, such as the nose and eyebrow. A concentration of 2.5% to 3.0% was usually necessary for treatment of Bowen's disease on the other body areas.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 528700     DOI: 10.1016/s0190-9622(79)80095-x

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  4 in total

1.  Keratinocyte carcinomas arising near arteriovenous fistulas: Case series and safety considerations for dermatologic surgery: A report of the International Transplant Skin Cancer Collaborative.

Authors:  Olivia M Lucero; Claudia Flores Echaiz; Fatemeh Jafarian; Matthew C Fox; John T Vetto; Reid V Mueller; Pedro G Teixeira; Fiona O Zwald; Justin J Leitenberger
Journal:  JAAD Case Rep       Date:  2018-12-04

2.  Superficial photodynamic therapy with topical 5-aminolaevulinic acid for superficial primary and secondary skin cancer.

Authors:  F Cairnduff; M R Stringer; E J Hudson; D V Ash; S B Brown
Journal:  Br J Cancer       Date:  1994-03       Impact factor: 7.640

3.  A Comparative Study Examining the Management of Bowen's Disease in the United Kingdom and Australia.

Authors:  G L Morley; J H Matthews; I Verpetinske; G A Thom
Journal:  Dermatol Res Pract       Date:  2015-09-09

Review 4.  Drug delivery nanoparticles in skin cancers.

Authors:  Chiara Dianzani; Gian Paolo Zara; Giovanni Maina; Piergiorgio Pettazzoni; Stefania Pizzimenti; Federica Rossi; Casimiro Luca Gigliotti; Eric Stefano Ciamporcero; Martina Daga; Giuseppina Barrera
Journal:  Biomed Res Int       Date:  2014-07-02       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.